Trial of Rectal Indomethacin to Prevent Acute Pancreatitis

Randomized Trial of Rectal Indomethacin to Prevent Acute Pancreatitis in Patients Undergoing Endoscopic Ultrasound-guided Fine Needle Aspiration of Pancreatic Cysts

  • Clinical Trial Information

    Trial Contact: Garcia de Djuro, Ginette; Britton, David ; Shepherd, Adriane R

  • IRB No: 22.085.04

    Protocol Abbrev: RECTAL-INDO-PAN-CYSTS

    Principal Investigator: Ji Young Bang, MD

    Age Group: Adult

    Secondary Protocol No: 22.085.04

    Treatment: Drug: Indomethacin rectal suppositories

    Therapies Involved: Medication ID: NCT05572788

  • Objective

    The primary outcome measure is to compare the rate of post-procedure pancreatitis following EUS-guided fine needle aspiration of pancreatic cysts between the indomethacin group and placebo group.

  • Key Eligibility

    1. Age ≥ 18 years
    2. Suspected or confirmed pancreatic cyst seen on imaging, requiring EUS-FNA